Over 25 pharmaceutical firms are collaborating to develop over 30 new treatments for celiac disease.

Over 25 major pharmaceutical companies are collaborating to develop more than 30 innovative treatments for celiac disease, aiming to revolutionize how the condition is treated. Notable companies like Takeda, Sanofi, Entero Therapeutics, and Pfizer are involved, with several therapies showing promise in early clinical trials. This growing pipeline reflects a significant push towards new treatments for those with celiac disease.

November 19, 2024
4 Articles